Delivering Global Health Impact Through People, Science and Technology

Emmes Group is the industry's first specialty, tech and AI based CRO, delivering programs better and faster, and helping bring new medical discoveries closer to patients.

News

❮
Press Release
Emmes Group® names Germaine Gross Chief Commercial Officer o…
Read More
Press Release
Emmes adds new role as it looks to expand government footpri…
Read More
Press Release
Emmes awarded multi-task, IDIQ contract with $50M ceiling, t…
Read More
Article
Rare Disease Day: Emmes Endpoints Solutions submits Duchenne…
Read More
Press Release
Dr. Rama Kondru Named Chief Executive Officer of Veridix AI
Read More
Press Release
Creation of the Emmes Group Will Advance Company’s 47-year L…
Read More
❯

Our Brands

Emmes veridix vaxtrails

OptymEdgeEssex

file

RFP

Submit an RFP Document

Submit
globe

2,150+

Phase I–IV trials in
90+ countries

note

434+

Publications in scientific
journals since 2016

location

32,000+

Clinical trial sites

history

History

Founded as Emmes more than 47 years ago, Emmes Group has grown to become one of the primary clinical research providers to the US government before expanding into public-private partnerships and commercial biopharma.

Learn More
leadership

Leadership

We are led by a dynamic team of visionaries who bring a wealth of experience, expertise and passion to drive our mission.

Learn More
careers

Careers

Join us in shaping the future of healthcare through groundbreaking research and innovation.

Learn More